Trial intelligence / Profile preview

Interleukin-2 and Maxamine in Metastatic Renal Cell Carcinoma

NCT00005038Phase 2Unknown

Sponsor
The Christie
Start
Jun 1999
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of histamine dihydrochloride in renal cell carcinoma (RCC), sponsored by The Christie. Status: unknown.

02

Drugs

histamine dihydrochloride
03

Conditions

renal cell carcinoma (RCC)

Beyond the preview

Go deeper on NCT00005038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call